The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Real Regulatory News (SREI)

Share Price Information for Schroder Real (SREI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.80
Bid: 44.60
Ask: 45.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.897%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 44.80
SREI Live PriceLast checked at -
Schroder Real Estate is an Investment Trust

To provide the shareholders with an attractive level of income, together with the potential for income and capital growth, from investing in a diversified portfolio of UK commercial real estate.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan re-financing completed Canada Life

16 Apr 2013 11:50

RNS Number : 4597C
Schroder Real Estate Inv Trst Ld
16 April 2013
 



Schroder Real Estate Investment Trust Limited

(the 'Company' / 'Group')

 

Loan re-financing COMPLETED with Canada Life Investments ('Canada Life')

 

Following the announcement on 15 March 2013, Schroder Real Estate Investment Trust Limited announces that it has now completed a new £129.58 million loan facility with Canada Life to refinance its £114.5 million securitised loan in full. The final key loan terms are:

 

·; Initial loan to value ('LTV'), ignoring cash held outside Canada Life's security, of 50%, calculated with reference to an independent valuation as at 15 January 2013

·; Total fixed interest rate of 4.77%, equating to an annual interest cost of approximately £6.18 million. This compares to an interest rate under the previous securitised loan of 5.72% or an annual interest cost of £6.55 million. The new loan should also realise a reduction in loan servicer fees of approximately £0.4 million per annum

·; 80% of the loan maturing in 15 years and 20% maturing in 10 years

·; No amortisation

·; LTV covenant of 65% and an interest cover ratio ('ICR') covenant of 185%

·; Flexibility to sell existing properties and acquire new properties

·; Flexibility to asset manage the portfolio including the ability to utilise cash from disposals to fund capital expenditure

·; Flexibility to make a limited number of voluntary prepayments. Fixed rate break costs are payable on any prepayment

 

Refinancing the securitised loan that matured in July 2014 has been a major strategic objective for the Company and the new facility satisfies the key criteria of achieving a long-term debt maturity, a reduction in the cost of debt and sufficient operational flexibility to permit continued active management of the portfolio.

 

As a condition of the refinancing the Company has broken its remaining interest rate swaps related to the securitised loan. This has crystallised a total swap break cost of £15.1 million which compared to the negative mark to market value in the Company's last reported Net Asset Value ('NAV') as at 31 December 2012 of £19.1 million. As the Canada Life loan benefits from a fixed rate there will no requirement for the Company to reflect a mark to market value of interest rate swaps in its NAV.

 

Having paid swap break costs and total re-finance fees estimated at £2.1 million, including an arrangement fee of approximately £1 million, the Company has cash outside Canada Life's security of £27.5 million. This results in a net loan to value, assuming the portfolio valuation as at 15 January 2013, of approximately 39%.

 

The successful refinancing of the loan will allow the Board, in turn, to consider the longer term sustainability of the dividend. The terms of the new loan will be taken into account alongside other factors, including the recent planning refusal at Reynards Trading Estate in Brentford. The Board will update shareholders in due course.

 

For further information:

 

Schroder Property Investment Management Limited:Duncan Owen / Nick Montgomery

020 7658 6000

Northern Trust:

David Sauvarin

01481 745529

FTI Consulting:

Dido Laurimore / Daniel O'Donnell

020 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAELKFLXDEFF
Date   Source Headline
29th Apr 20247:00 amRNSNotice of Results
13th Mar 20244:44 pmRNSHolding(s) in Company
8th Mar 20245:01 pmRNSHolding(s) in Company
6th Mar 20245:46 pmRNSHolding(s) in Company
6th Mar 20245:42 pmRNSHolding(s) in Company
29th Feb 20242:13 pmRNSInvestor Presentation
27th Feb 20247:00 amRNSNAV and Dividend for Quarter to 31 December 2023
26th Jan 20245:02 pmRNSQuotedData's Weekly News & Interview
26th Jan 20244:23 pmRNSQuotedData's Weekly News & Interview
15th Dec 20231:03 pmRNSResult of EGM
11th Dec 202312:13 pmRNSHolding(s) in Company
21st Nov 20238:35 amRNSWebinar details
21st Nov 20237:01 amRNSDividend Announcement for the Quarter to 30 Sep 23
21st Nov 20237:00 amRNSPublication of circular and notice of EGM
21st Nov 20237:00 amRNSInterim Results for the period ended 30 Sept 2023
1st Nov 20237:00 amRNSNon-Executive Director Change
18th Oct 20234:08 pmRNSInvestor Presentation
27th Sep 20234:54 pmRNSResult of AGM
26th Sep 20234:47 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSNotice of Results
8th Sep 202311:21 amRNSHolding(s) in Company
27th Jul 20232:43 pmRNSAnnual Report for year ended 31 March 2023
27th Jul 20232:11 pmRNSInvestor Presentation
27th Jul 20237:00 amRNSNAV and Dividend for the Quarter to 30 June 2023
8th Jun 20236:26 pmRNSDividend PID Status
8th Jun 202311:29 amRNSHolding(s) in Company
8th Jun 20237:01 amRNSDividend Declaration
8th Jun 20237:00 amRNSFull Year Results for the year ended 31 March 2023
2nd Jun 202311:18 amRNSInvestor Presentation
2nd May 20239:00 amRNSNotice of Full Year Results
20th Apr 202310:12 amRNSDirector Declaration
10th Mar 20232:12 pmRNSDirector/PDMR Shareholding
1st Mar 20234:34 pmRNSHolding(s) in Company
3rd Feb 20234:13 pmRNSInvestor Presentation
3rd Feb 20237:00 amRNSNAV and Dividend for the quarter to 30 Dec 2022
12th Dec 20227:00 amRNSKepler Trust Intelligence: New Research
1st Dec 20224:41 pmRNSHolding(s) in Company
16th Nov 20227:01 amRNSDividend Declaration
16th Nov 20227:01 amRNSDirectorate Change
16th Nov 20227:00 amRNSInterim results for the period ended 30 September
19th Oct 20227:00 amRNSInvestor Presentation
12th Oct 20227:00 amRNSNotice of Half Year Results
30th Sep 20224:53 pmRNSTotal Voting Rights
21st Sep 20224:10 pmRNSResult of AGM
15th Sep 20225:34 pmRNSTransaction in Own Shares
14th Sep 20225:18 pmRNSTransaction in Own Shares
13th Sep 20225:21 pmRNSTransaction in Own Shares
12th Sep 20225:33 pmRNSTransaction in Own Shares
9th Sep 20225:33 pmRNSTransaction in Own Shares
8th Sep 20225:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.